{"id":"W2979874565","doi":"10.1016/j.jacl.2019.10.003","title":"Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharma; Miltenyi Biotec; Amgen","keywords":"Evolocumab; Medicine; Apheresis; Clinical endpoint; Randomized controlled trial; Internal medicine; Alirocumab; Gastroenterology; Urology; Lipoprotein; Cholesterol; Endocrinology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00269621,0.000880548,0.00193805,0.0002422673,0.0002733766,0.0008635022,0.000655334,0.001130462,0.003004747],"category_scores_gemma":[0.002901647,0.0004017297,0.001924203,0.0001957553,0.0008840384,0.0006896027,0.000376598,0.001679979,0.0003617066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007030389,"about_ca_system_score_gemma":0.0008367124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007158861,"about_ca_topic_score_gemma":0.001646282,"domain_scores_codex":[0.9982187,0.001248771,0.00009372254,0.0001716595,0.0001426686,0.0001243927],"domain_scores_gemma":[0.9973921,0.001105325,0.0006225287,0.0002227878,0.0001309582,0.0005263197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9826663,0.003660686,0.00120515,0.0002383984,0.000999086,0.00001660233,0.00002739918,0.0001483837,0.001366302,0.00004705522,0.0002407485,0.009383876],"study_design_scores_gemma":[0.942216,0.04986777,0.005758727,0.00002934747,0.0007772862,0.00002421669,0.00001472582,0.000425699,0.0003970643,0.00006694724,0.0004079349,0.00001441693],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939122,0.003110656,0.0003765342,0.0003745792,0.000174835,0.000642977,0.0005425489,0.0000356239,0.0008299481],"genre_scores_gemma":[0.9950964,0.001100531,0.0008955012,0.00042337,0.0002557256,0.0006613073,0.0004556901,0.00001246311,0.001099016],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003004747,"threshold_uncertainty_score":0.0142591,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06162361087302733,"score_gpt":0.4142984293133187,"score_spread":0.3526748184402914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}